Inhibition of histone acetyltransferase attenuates 3D chromatin-mediated insulin signaling in pancreatic cancer (RNAseq dataset)

Inhibition of histone acetyltransferase has been widely used to be effectively treat cancers in many studies. However, it’s not clear how the downstream signaling responds to the inhibitor in pancreatic cancer. Here we performed Hi-C experiments and RNA-seq to canonical and patient-derived pancreatic cancer cells with the treatment of small molecule inhibitor ICG-001 which has dual function to block both WNT signaling and histone acetyltransferase. This is RNA-seq dataset. Four kinds of cell lines including the pancreatic cancer cell line PANC1, and two newly established cell lines from patient-derived tumor xenograft (PATX) program PATC53 and PATC50, and human pancreatic epithelial cell line HPNE were treated with ICG-001 at the concentration of 10 µM for 48 hours. Then RNA-seq experiments were performed for these cells.